{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T02:23:57Z","timestamp":1782959037889,"version":"3.54.5"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Mesothelin (MSLN) is a surface antigen highly expressed in several solid tumors, including mesothelioma, ovarian, and pancreatic cancers. However, therapeutic efficacy of MSLN-targeted agents is often compromised by shed MSLN (SM), which acts as a soluble decoy and accumulates in tumor microenvironments, reducing antibody engagement at the tumor surface.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To overcome this barrier, we generated antibodies targeting the membrane-proximal, non-shed region of MSLN using a peptide encompassing major cleavage sites for rabbit immunization. From 200 B-cell clones, 14 antibodies specific to the juxtamembrane region of MSLN were identified. The lead candidate, RO4, underwent detailed characterization and humanization to improve clinical applicability.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Humanized RO4 (hRO4) exhibited enhanced binding affinity to MSLN and specifically recognized tumor-associated, non-shed epitopes. Structural analysis confirmed precise epitope engagement near the cleavage site. hRO4 effectively inhibited mesothelin shedding in vitro and enabled potent tumor eradication when expressed in chimeric antigen receptor (CAR) T cells in NOD scid gamma mouse models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Targeting a non-shed epitope of MSLN with hRO4 overcomes a critical limitation of conventional MSLN-directed therapies. By avoiding decoy interference and enhancing tumor-specific targeting, hRO4-based therapeutics offer promising clinical potential for improving outcomes in MSLN-positive cancers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/abt\/tbaf022","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:22:37Z","timestamp":1761830557000},"page":"1-12","source":"Crossref","is-referenced-by-count":2,"title":["RO4, a high-affinity humanized antibody against the juxtamembrane region of mesothelin for targeted cancer therapy"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6805-2152","authenticated-orcid":false,"given":"Masanori","family":"Onda","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufen","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenlong","family":"Liu","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8940-3663","authenticated-orcid":false,"given":"Jingyu","family":"Zhan","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn A","family":"Maslanka","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Xia","sequence":"additional","affiliation":[{"name":"Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9152-5405","authenticated-orcid":false,"given":"Mitchell","family":"Ho","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Pastan","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health , Bethesda, MD 20892 ,","place":["United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"key":"2026050904364557500_ref1","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ordonez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"2026050904364557500_ref2","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1073\/pnas.93.1.136","article-title":"Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers","volume":"93","author":"Chang","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050904364557500_ref3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/ijc.2910500308","article-title":"Isolation and characterization of a monoclonal antibody, K1, reactive with ovarian cancers and normal mesothelium","volume":"50","author":"Chang","year":"1992","journal-title":"Int J Cancer"},{"key":"2026050904364557500_ref4","doi-asserted-by":"publisher","first-page":"5915","DOI":"10.1158\/0008-5472.CAN-11-0466","article-title":"Cytotoxic activity of immunotoxin SS1P is modulated by TACE-dependent mesothelin shedding","volume":"71","author":"Zhang","year":"2011","journal-title":"Cancer Res"},{"key":"2026050904364557500_ref5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s42003-020-01464-5","article-title":"Multiple proteases are involved in mesothelin shedding by cancer cells","volume":"3","author":"Liu","year":"2020","journal-title":"Commun Biol"},{"key":"2026050904364557500_ref6","doi-asserted-by":"publisher","first-page":"17099","DOI":"10.1073\/pnas.0708101104","article-title":"Immunotoxin and taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050904364557500_ref7","first-page":"5151","article-title":"Loss of mesothelin expression by mesothelioma cells grown in vitro determines sensitivity to anti-mesothelin immunotoxin SS1P","volume":"32","author":"Zhang","year":"2012","journal-title":"Anticancer Res"},{"key":"2026050904364557500_ref8","doi-asserted-by":"publisher","first-page":"e2202439119","DOI":"10.1073\/pnas.2202439119","article-title":"Highly active CAR T cells that bind to a juxtamembrane region of mesothelin and are not blocked by shed mesothelin","volume":"119","author":"Liu","year":"2022","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050904364557500_ref9","doi-asserted-by":"publisher","first-page":"e2317283121","DOI":"10.1073\/pnas.2317283121","article-title":"Tumor resistance to anti-mesothelin CAR-T cells caused by binding to shed mesothelin overcome by targeting a juxtamembrane epitope","volume":"121","author":"Liu","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026050904364557500_ref10","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1158\/1535-7163.MCT-23-0233","article-title":"A bispecific antibody targets the membrane-proximal region of mesothelin and retains high anticancer activity in the presence of shed mesothelin","volume":"23","author":"Chakraborty","year":"2024","journal-title":"Mol Cancer Ther"},{"key":"2026050904364557500_ref11","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1038\/emm.2017.23","article-title":"From rabbit antibody repertoires to rabbit monoclonal antibodies","volume":"49","author":"Weber","year":"2017","journal-title":"Exp Mol Med"},{"key":"2026050904364557500_ref12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1021\/acs.analchem.5b03637","article-title":"Simultaneous raising of rabbit monoclonal antibodies to fluoroquinolones with diverse recognition functionalities via single mixture immunization","volume":"88","author":"Liu","year":"2016","journal-title":"Anal Chem"},{"key":"2026050904364557500_ref13","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1097\/PAI.0b013e3182a4edef","article-title":"A new rabbit monoclonal E-cadherin antibody [EP700Y] shows higher sensitivity than mouse monoclonal E-cadherin [HECD-1] antibody in breast ductal carcinomas and does not stain breast lobular carcinomas","volume":"22","author":"Hoang","year":"2014","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2026050904364557500_ref14","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1097\/PAI.0b013e318284a03a","article-title":"Validation and comparison of anti-\u03b1v\u03b23 and anti-\u03b1v\u03b25 rabbit monoclonal versus murine monoclonal antibodies in four different tumor entities","volume":"21","author":"Boger","year":"2013","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"2026050904364557500_ref15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1309\/NR8HN08GDPVEMU08","article-title":"Rabbit monoclonal antibodies: a comparative study between a novel category of immunoreagents and the corresponding mouse monoclonal antibodies","volume":"124","author":"Rossi","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"2026050904364557500_ref16","doi-asserted-by":"publisher","first-page":"9189","DOI":"10.18632\/oncotarget.13984","article-title":"Mesothelin-targeted immunotoxin RG7787 has synergistic anti-tumor activity when combined with taxanes","volume":"8","author":"Kolyvas","year":"2017","journal-title":"Oncotarget"},{"key":"2026050904364557500_ref17","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.clcc.2019.06.006","article-title":"Anti-mesothelin recombinant immunotoxin therapy for colorectal cancer","volume":"18","author":"Cerise","year":"2019","journal-title":"Clin Colorectal Cancer"},{"key":"2026050904364557500_ref18","doi-asserted-by":"publisher","first-page":"5637","DOI":"10.1200\/JCO.2005.05.4155","article-title":"Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival","volume":"24","author":"Cheang","year":"2006","journal-title":"J Clin Oncol"},{"key":"2026050904364557500_ref19","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1158\/2767-9764.CRC-22-0306","article-title":"Structures of cancer antigen mesothelin and its complexes with therapeutic antibodies","volume":"3","author":"Zhan","year":"2023","journal-title":"Cancer Res Commun"},{"key":"2026050904364557500_ref20","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol"},{"key":"2026050904364557500_ref21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1107\/S0907444907050172","article-title":"BALBES: a molecular-replacement pipeline","volume":"64","author":"Long","year":"2008","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2026050904364557500_ref22","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"Collaborative Computational Project, Number 4. The CCP4 suite: programs for protein crystallography","volume":"50","year":"1994","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2026050904364557500_ref23","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: Model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"2026050904364557500_ref24","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1107\/S2059798318006551","article-title":"Real-space refinement in PHENIX for cryo-EM and crystallography","volume":"74","author":"Afonine","year":"2018","journal-title":"Acta Crystallogr D Struct Biol"},{"key":"2026050904364557500_ref25","first-page":"14","article-title":"The IgG4 hinge with CD28 transmembrane domain improves VHH-based CAR T cells targeting a membrane-distal epitope of GPC1 in pancreatic cancer","volume":"2023","author":"Li","year":"1986","journal-title":"Nat Commun"},{"key":"2026050904364557500_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100942","article-title":"Preclinical testing of chimeric antigen receptor T cells in neuroblastoma mouse models","volume":"2","author":"Li","year":"2021","journal-title":"STAR Protocols"},{"key":"2026050904364557500_ref27","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1080\/19420862.2017.1289302","article-title":"Humanization of rabbit monoclonal antibodies via grafting combined Kabat\/IMGT\/Paratome complementarity-determining regions: rationale and examples","volume":"9","author":"Zhang","year":"2017","journal-title":"mAbs"},{"key":"2026050904364557500_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100297","article-title":"CAR T cells targeting tumor-associated exons of glypican 2 regress neuroblastoma in mice","volume":"2","author":"Li","year":"2021","journal-title":"Cell Rep Med"},{"key":"2026050904364557500_ref29","doi-asserted-by":"publisher","first-page":"7981","DOI":"10.1158\/1078-0432.CCR-08-0324","article-title":"High shed antigen levels within tumors: an additional barrier to immunoconjugate therapy","volume":"14","author":"Zhang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"2026050904364557500_ref30","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1158\/1535-7163.MCT-15-0863","article-title":"Reduced shedding of surface mesothelin improves efficiency of mesothelin-targeting recombinant immunotoxins","volume":"15","author":"Awuah","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"2026050904364557500_ref31","doi-asserted-by":"publisher","first-page":"3596","DOI":"10.1158\/0008-5472.CAN-15-0159","article-title":"Affinity-tuned ErbB2 or EGFR chimeric antigen receptor T cells exhibit an increased therapeutic index against tumors in mice","volume":"75","author":"Liu","year":"2015","journal-title":"Cancer Res"},{"key":"2026050904364557500_ref32","doi-asserted-by":"publisher","first-page":"eabd8836","DOI":"10.1126\/scitranslmed.abd8836","article-title":"SynNotch CAR circuits enhance solid tumor recognition and promote persistent antitumor activity in mouse models","volume":"13","author":"Hyrenius-Wittsten","year":"2021","journal-title":"Sci Transl Med"},{"key":"2026050904364557500_ref33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.cell.2016.01.011","article-title":"Precision tumor recognition by T cells with combinatorial antigen-sensing circuits","volume":"164","author":"Roybal","year":"2016","journal-title":"Cell"}],"container-title":["Antibody Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/abt\/advance-article-pdf\/doi\/10.1093\/abt\/tbaf022\/65042503\/tbaf022.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/abt\/article-pdf\/9\/1\/1\/67314447\/tbaf022.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/abt\/article-pdf\/9\/1\/1\/67314447\/tbaf022.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:36:52Z","timestamp":1778315812000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/abt\/article\/9\/1\/1\/8306900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,14]]}},"URL":"https:\/\/doi.org\/10.1093\/abt\/tbaf022","relation":{},"ISSN":["2516-4236"],"issn-type":[{"value":"2516-4236","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,10,30]]}}}